22nd Feb 2012 16:46
RNS Number : 9352X
AGI Therapeutics plc
22 February 2012
AGI Therapeutics plc ('AGI')
Holding in Company
AGI was notified on 22 February 2012 that as of 16 February 2012 Aravis Therapeutics Limited has a shareholding of 60,784,191 ordinary shares of €0.10 each representing 90.17 per cent of AGI's entire issued share capital.
Contact Information
AGI Therapeutics
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Potentially Ai